{
    "Trade/Device Name(s)": [
        "OSOM\u00ae Influenza A&B Test"
    ],
    "Submitter Information": "Sekisui Diagnostics, LLC",
    "510(k) Number": "K123182",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092633"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "October 5, 2012",
    "Summary Letter Received Date": "October 10, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab"
    ],
    "Specimen Container(s)": [
        "Swab"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Reagent",
        "Strip test"
    ],
    "Document Summary": "FDA 510(k) summary for OSOM\u00ae Influenza A&B Test, lateral flow immunochromatographic assay for qualitative detection of influenza A and B antigens from nasal swabs",
    "Indications for Use Summary": "Intended for qualitative detection of influenza A and B viral nucleoprotein antigens from nasal swab specimens in symptomatic patients to aid in the rapid differential diagnosis of influenza A and/or B viral infections; not intended for influenza C, negative results are presumptive and should be confirmed by cell culture",
    "fda_folder": "Microbiology"
}